Yuan Y, Fu M, Li N, Ye M
Who Can Benefit from IV Therapy
In addition, a disorder known as Laron syndrome which is associated with low circulating levels of IGF1 and IGFBP3 25 are protected from developing cancer, but instead can develop diabetes and cardiovascular disease 26
More and more consumers are moving beyond generic multivitamins and looking for targeted solutions that address specific age-related concerns at a cellular level
To date, 5 types of DPP-4 inhibitors are approved for clinical use: sitagliptin, saxagliptin, vildagliptin, linagliptin and alogliptin
But the special feature is the synergistic combination with alpha-lipoic acid, N-acetylcysteine, zinc, selenium, and bioactive B vitamins